Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Enveric Biosciences (ENVB)
NASDAQ:ENVB
Holding ENVB?
Track your performance easily
ENVB Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.33 - $2.92
Previous Close$0.35
Volume279.16K
Average Volume (3M)509.94K
Market Cap
$3.53M
Enterprise Value$418.76K
Total Cash (Recent Filing)$3.11M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.42
Next Earnings
Mar 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.56
Shares Outstanding9,944,920
10 Day Avg. Volume431,038
30 Day Avg. Volume509,938
Standard Deviation0.30
R-Squared0.01
Alpha-0.08
Financial Highlights & Ratios
Price to Book (P/B)0.88
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.08
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Enveric Biosciences News
PremiumPre-Earnings
Is ENVB a Buy, Before Earnings?
Ownership Overview
8.78% Insiders
2.41% Mutual Funds
3.92% Other Institutional Investors
78.67% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
ENVB FAQ
What was Enveric Biosciences’s price range in the past 12 months?
Enveric Biosciences lowest stock price was $0.33 and its highest was $2.92 in the past 12 months.
What is Enveric Biosciences’s market cap?
Currently, no data Available
When is Enveric Biosciences’s upcoming earnings report date?
Enveric Biosciences’s upcoming earnings report date is Mar 27, 2025 which is in 125 days.
How were Enveric Biosciences’s earnings last quarter?
Enveric Biosciences released its earnings results on Nov 14, 2024. The company reported -$0.24 earnings per share for the quarter, beating the consensus estimate of -$0.52 by $0.28.
Is Enveric Biosciences overvalued?
According to Wall Street analysts Enveric Biosciences’s price is currently Overvalued.
Does Enveric Biosciences pay dividends?
Enveric Biosciences does not currently pay dividends.
What is Enveric Biosciences’s EPS estimate?
Enveric Biosciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Enveric Biosciences have?
Enveric Biosciences has 9,944,920 shares outstanding.
What happened to Enveric Biosciences’s price movement after its last earnings report?
Enveric Biosciences reported an EPS of -$0.24 in its last earnings report, beating expectations of -$0.52. Following the earnings report the stock price went down -10%.
Which hedge fund is a major shareholder of Enveric Biosciences?
Currently, no hedge funds are holding shares in ENVB
---
Enveric Biosciences Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-76.09%
12-Months-Change
Fundamentals
Return on Equity
-308.65%
Trailing 12-Months
Asset Growth
-27.63%
Trailing 12-Months
Company Description
Enveric Biosciences
Ameri Holdings, Inc. specializes in delivering SAP cloud, digital and enterprise services to clients worldwide. Its services center around SAP and include technology consulting, business intelligence, cloud services, application development/integration and maintenance, implementation services, infrastructure services, and independent validation services, all of which can be delivered as a set of managed services or on an on-demand service basis, or a combination of both. The company was founded by Srinidhi Devanur in February 1994 and is headquartered in Suwanee, GA.
---
ENVB Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Relmada Therapeutics
―
ATAI Life Sciences
―
Mind Medicine
―
SELLAS Life Sciences Group
―
Best Analysts Covering ENVB
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-56.30%
initiated a buy rating 10 months ago
Copying Vernon Bernardino's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -56.30% per trade.
---